Histopathology of carcinomas of the liver in mice fed perthane.
M D Reuber
Index: Tumori 66(3) , 277-83, (1980)
Full Text: HTML
Abstract
B6C3F1 female mice fed an average dose of 3,000 ppm of perthane for 2 years developed a highly significant incidence of hepatocellular carcinomas of the liver. Male mice fed 2,500 ppm perthane had a slight increase of carcinoma of the liver. Some of the carcinomas were well-differentiated; however, most were poorly differentiated or undifferentiated. Perthane-treated mice also had well and poorly differentiated cholangiocarcinomas and carcinosarcomas, neoplasms not seen in control mice.
Related Compounds
Related Articles:
Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals.
2009-09-01
[Eur. J. Med. Chem. 44 , 3658-64, (2009)]
1990-01-01
[J. Anal. Toxicol. 14(3) , 143-5, (1990)]
Rapid decline of persistent organochlorine pollutants in serum among young Swedish males.
2008-02-01
[Chemosphere 70(9) , 1620-8, (2008)]
2007-04-13
[J. Chromatogr. A. 1147(1) , 10-6, (2007)]
O,P'DDD IN THE TREATMENT OF ADVANCED MAMMARY CARCINOMA.
1964-10-01
[Cancer 17 , 1258-66, (1964)]